Literature DB >> 12378512

Abnormalities of the ARF-p53 pathway in primary angiosarcomas of the liver.

Markus Weihrauch1, Anett Markwarth, Gerhard Lehnert, Christian Wittekind, Renate Wrbitzky, Andrea Tannapfel.   

Abstract

The INK4a-ARF locus, located on chromosome 9p21, encodes 2 cell cycle-regulatory proteins, p16(INKa) and p14(ARF), acting through the Rb-CDK4 and p53 pathways. This study was done to investigate the contribution of the INK4a-ARF locus in tumorigenesis of angiosarcoma of the liver. Alterations of p14(ARF), p16(INKa), and p53 in primary liver angiosarcoma from 19 patients were analyzed by methylation-specific polymerase chain reaction (MSP), restriction enzyme-related polymerase chain reaction (RE-PCR), microsatellite analysis, and DNA sequencing. As a control group, 12 angiosarcomas from other organs were analyzed. Promoter methylation of p14(ARF) was found in 5 of 19 cases (26%), and p16(INKa) showed aberrant promoter methylation in 12 of 19 cases (63%). One tumor (5%) had homozygous deletion of the INK4a-ARF locus. Methylation and deletion correlated with loss of mRNA transcription. Methylated p14(ARF) appeared in the context of a methylated p16(INKa) promoter in 3 cases of the 5 angiosarcomas methylated at p14(ARF). p14(ARF) aberrant methylation was not related to the presence of p53 mutations, which was detected in 6 of 19 (32%) cases. Alterations of the INK4a-ARF locus or p53 as were not established independent prognostic factors in these tumors. In conclusion, our data indicate that the INK4a-ARF locus is frequently inactivated in angiosarcoma of the liver and occurs independently of p53 mutations. Copyright 2002, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12378512     DOI: 10.1053/hupa.2002.126880

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  15 in total

1.  Pediatric hepatic hemangiosarcoma in a rhesus macaque (Macaca mulatta).

Authors:  A F Mejía; L Gierbolini; B Jacob; S V Westmoreland
Journal:  J Med Primatol       Date:  2008-07-30       Impact factor: 0.667

2.  ARF suppresses hepatic vascular neoplasia in a carcinogen-exposed murine model.

Authors:  Stephanie E Busch; Kay E Gurley; Russell D Moser; Christopher J Kemp
Journal:  J Pathol       Date:  2012-05-08       Impact factor: 7.996

Review 3.  [Primary sarcomas and sarcoma metastases in the liver: morphological and molecular aspects].

Authors:  G Mechtersheimer; R Penzel; W J Hofmann; P Schirmacher
Journal:  Pathologe       Date:  2006-07       Impact factor: 1.011

Review 4.  Epigenetic alterations induced by genotoxic occupational and environmental human chemical carcinogens: A systematic literature review.

Authors:  Grace Chappell; Igor P Pogribny; Kathryn Z Guyton; Ivan Rusyn
Journal:  Mutat Res Rev Mutat Res       Date:  2016-03-31       Impact factor: 5.657

5.  Primary vascular tumors of bone: a spectrum of entities?

Authors:  Sofie L J Verbeke; Judith V M G Bovée
Journal:  Int J Clin Exp Pathol       Date:  2011-07-25

6.  Hepatic small vessel neoplasm, a rare infiltrative vascular neoplasm of uncertain malignant potential.

Authors:  Ryan M Gill; Benjamin Buelow; Cheryl Mather; Nancy M Joseph; Venancio Alves; Elizabeth M Brunt; Ta-Chiang Liu; Hala Makhlouf; Celia Marginean; ILKe Nalbantoglu; Christine Sempoux; Dale C Snover; Swan N Thung; Matthew M Yeh; Linda D Ferrell
Journal:  Hum Pathol       Date:  2016-04-14       Impact factor: 3.466

7.  INK4a/ARF [corrected] inactivation with activation of the NF-κB/IL-6 pathway is sufficient to drive the development and growth of angiosarcoma.

Authors:  Jinming Yang; Sara Kantrow; Jiqing Sai; Oriana E Hawkins; Mark Boothby; Gregory D Ayers; Eric D Young; Elizabeth G Demicco; Alexander J Lazar; Dina Lev; Ann Richmond
Journal:  Cancer Res       Date:  2012-07-26       Impact factor: 12.701

Review 8.  Therapeutic targets in the ARF tumor suppressor pathway.

Authors:  Anthony J Saporita; Leonard B Maggi; Anthony J Apicelli; Jason D Weber
Journal:  Curr Med Chem       Date:  2007       Impact factor: 4.530

9.  Endothelial cell dysfunction and cytoskeletal changes associated with repression of p16(INK4a) during immortalization.

Authors:  C-Y Kan; V W Wen; E Pasquier; K Jankowski; M Chang; L A Richards; M Kavallaris; K L MacKenzie
Journal:  Oncogene       Date:  2012-02-06       Impact factor: 9.867

Review 10.  Modeling human endothelial cell transformation in vascular neoplasias.

Authors:  Victoria W Wen; Karen L MacKenzie
Journal:  Dis Model Mech       Date:  2013-09       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.